Efficacy of Oral Arginine as Treatment to Improve Height in Prepubertal Children With Idiopathic Short Stature: A Systematic Review and Meta-Analysis

Read full text Summarise with VIRAT
Authors: Manuel André Virú-Loza, Ruth Elizabeth Chávez-Nomberto, Adrián Vladimir Hernández
Cited by: 0
References: 28

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Arginine can stimulate growth hormone production. However, a synthesis of the evidence on the effect in children's height is lacking. Objectives: To systematically evaluate the efficacy of oral arginine in improving height in prepubertal children with idiopathic short stature. Design: Systematic review and meta-analysis. Data sources and methods: We included clinical trials and cohort studies. We searched in 7 databases until May 31, 2025. Effects were pooled using standardized mean differences (SMDs) and re-expressed as mean differences (MDs). Results: We only found low-quality studies. Oral arginine administered for 6 or 12 months increased growth velocity (SMD 0.66, 95% CI 0.21-1.12), but the benefit was clinically small (re-expressed MD 0.59 cm/year [95% CI 0.19-1.00]), and the effect was not statistically significant when administered for exclusively 12 months. Conclusion: Oral arginine administered for 12 months may not affect growth. Well-designed RCTs are required. Registration: PROSPERO (CRD42024503778).

Fields of Study & Subjects

Growth Hormone and Insulin-like Growth Factors Hypothalamic control of reproductive hormones Human Health and Disease

Publication details

Journal / source
Sage Open Pediatrics
Volume
13
Pages
30502225261433767–30502225261433767
Publication date
1 March 2026
Language
EN